RHOA and neoplasm: These antibodies can induce NK cell infiltration into tumors by binding to CXCL16, while simultaneously activating Ras Homolog Family Member A (RhoA) through the extracellular signal-regulated kinase (ERK) signaling cascade, further boosting NK cell-mediated tumor targeting [39].